Brief: China Pioneer Pharma Enters Agreement For Sale Of Ophthalmic Pharmaceutical Products

Shanghai Pioneer Holding

28/12/2017 04:04

Dec 28 (Reuters) - China Pioneer Pharma Holdings Ltd 
 1345.HK : 
    * CO ENTERED AGREEMENT WITH ALCON AND AFFILIATE BEIJING 
NOVARTIS 
PHARMACEUTICAL CO FOR SALE OF OPHTHALMIC PHARMACEUTICAL PRODUCTS 
    * PARTIES AGREE THAT ALCON & BEIJING NOVARTIS TO CONTINUE TO 
SUPPLY MINIMUM VALUE OF ALCON PRODUCTS TO CO FOR YEAR ENDING DEC 
2018 
    *  TOTAL VALUE OF ALCON PRODUCTS WHICH GROUP MAY SELL IN 
2018 
WILL BE NO LESS THAN RMB617 MILLION (NET OF TAX) 
 
Source text for Eikon:  ID:nHKSbGdvKY  
Further company coverage:  1345.HK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))